Government accepts all 44 recommendations from regulation of AI in healthcare report
The government said its acceptance commits the UK to develop a world-leading agile approach to AI device regulation that would...
Nine in ten patients had ‘clinically relevant genetic variation in pharmacogenomics pilot
The PROGRESS trial for pharmacogenomic guided prescribing in primary care enrolled more than 1,300 patients across 21 sites....
Tase Oputu: ‘Be part of the conversation. Nobodys opinions are invalid
Tase Oputu, president of the Royal College of Pharmacy (RCPharm), talks about her experiences of leading the College and outlines...
Patient safety alert issued as insulin treatment switching lags behind discontinuation deadline
Clinicians have been told that patients must be switched from Levemir, used to treat diabetes, by the end of November...
No clear increase in pregnancy risks after GLP-1 exposure, study suggests
The study authors warned that the findings should not be read as proof that GLP-1 medicines are safe to use...
Overcoming impostor syndrome and making a difference on the UKCPA neuroscience committee
Impostor syndrome is a problem many people face while breaking into a sector — especially pharmacy — but how does...